SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEART
This work was supported by Hjärt-Lungfonden, Vetenskapsrådet, Knut and Alice Wallenberg Foundation, ALF, the Bundy Academy, and Skåne University Hospital funds.
Authors
- Tomas Jernberg (ORCID: https://orcid.org/0000-0003-1695-379X)
- David Erlinge (ORCID: https://orcid.org/0000-0003-3042-5766)
- H C Rosen (ORCID: https://orcid.org/0000-0003-1967-1851)
- Jonas Oldgren (ORCID: https://orcid.org/0000-0002-9969-3921)
- Moman A. Mohammad (ORCID: https://orcid.org/0000-0003-4242-9801)
- Stefan James
Institutions
- Uppsala University (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.lanepe.2024.101032
- Citations
- 17
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.08
Funders
- Hjärt-Lungfonden
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Skånes universitetssjukhus
- Stiftelsen Bundy Academy